Massachusetts Financial Services Co. MA Purchases 2,883,382 Shares of Healthpeak Properties, Inc. $DOC

Massachusetts Financial Services Co. MA boosted its position in Healthpeak Properties, Inc. (NYSE:DOC) by 214.0% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,230,551 shares of the real estate investment trust’s stock after purchasing an additional 2,883,382 shares during the quarter. Massachusetts Financial Services Co. MA’s holdings in Healthpeak Properties were worth $98,050,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently bought and sold shares of DOC. Norges Bank purchased a new position in shares of Healthpeak Properties during the 4th quarter valued at $153,550,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in Healthpeak Properties by 694.6% during the third quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust’s stock valued at $153,520,000 after buying an additional 7,007,777 shares during the period. Bank of New York Mellon Corp boosted its stake in Healthpeak Properties by 60.3% during the first quarter. Bank of New York Mellon Corp now owns 15,456,420 shares of the real estate investment trust’s stock valued at $253,949,000 after buying an additional 5,815,189 shares during the period. Fuller & Thaler Asset Management Inc. grew its position in Healthpeak Properties by 19.2% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust’s stock worth $476,744,000 after buying an additional 4,776,056 shares in the last quarter. Finally, Bank of America Corp DE grew its position in Healthpeak Properties by 27.5% during the first quarter. Bank of America Corp DE now owns 11,887,795 shares of the real estate investment trust’s stock worth $195,316,000 after buying an additional 2,563,407 shares in the last quarter. 93.57% of the stock is owned by institutional investors.

Healthpeak Properties Stock Down 0.1%

Shares of NYSE DOC opened at $20.78 on Friday. Healthpeak Properties, Inc. has a one year low of $15.70 and a one year high of $22.95. The company has a debt-to-equity ratio of 1.06, a current ratio of 3.02 and a quick ratio of 3.02. The firm’s 50 day simple moving average is $21.33 and its two-hundred day simple moving average is $18.90. The stock has a market capitalization of $14.33 billion, a P/E ratio of 59.38, a PEG ratio of 3.20 and a beta of 1.01.

Healthpeak Properties (NYSE:DOC) last posted its quarterly earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 EPS for the quarter, topping the consensus estimate of $0.03 by $0.05. The firm had revenue of $771.58 million for the quarter, compared to the consensus estimate of $725.64 million. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. The business’s revenue was up 11.1% compared to the same quarter last year. During the same period last year, the firm posted $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. As a group, analysts expect that Healthpeak Properties, Inc. will post 1.77 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The firm also recently announced a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be given a $0.1017 dividend. This represents a c) dividend on an annualized basis and a yield of 5.9%. The ex-dividend date is Monday, September 14th. Healthpeak Properties’s dividend payout ratio (DPR) is presently 348.57%.

Analyst Ratings Changes

DOC has been the topic of a number of research analyst reports. Raymond James Financial assumed coverage on Healthpeak Properties in a research note on Wednesday, June 17th. They issued a “market perform” rating on the stock. Morgan Stanley reissued an “equal weight” rating and set a $22.00 price objective (up from $20.00) on shares of Healthpeak Properties in a report on Thursday, June 11th. Wells Fargo & Company upped their price objective on shares of Healthpeak Properties from $20.00 to $22.00 and gave the stock an “equal weight” rating in a research report on Wednesday, July 15th. BMO Capital Markets raised their target price on shares of Healthpeak Properties from $20.00 to $24.00 and gave the company an “outperform” rating in a research note on Monday, June 15th. Finally, Citigroup lifted their target price on shares of Healthpeak Properties from $20.00 to $22.00 and gave the company a “neutral” rating in a research report on Tuesday. Four investment analysts have rated the stock with a Buy rating and fifteen have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Healthpeak Properties currently has an average rating of “Hold” and a consensus price target of $21.44.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.